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Pseudomonas aeruginosa inhibits 
Rhizopus microsporus germination 
through sequestration of free 
environmental iron
Courtney Kousser, Callum Clark, sarah sherrington, Kerstin Voelz & Rebecca A. Hall  
Rhizopus spp are the most common etiological agents of mucormycosis, causing over 90% mortality 
in disseminated infection. Key to pathogenesis is the ability of fungal spores to swell, germinate, and 
penetrate surrounding tissues. Antibiotic treatment in at-risk patients increases the probability of the 
patient developing mucormycosis, suggesting that bacteria have the potential to control the growth 
of the fungus. However, research into polymicrobial relationships involving Rhizopus spp has not 
been extensively explored. Here we show that co-culturing Rhizopus microsporus and Pseudomonas 
aeruginosa results in the inhibition of spore germination. this inhibition was mediated via the 
secretion of bacterial siderophores, which induced iron stress on the fungus. Addition of P. aeruginosa 
siderophores to R. microsporus spores in the zebrafish larval model of infection resulted in inhibition of 
fungal germination and reduced host mortality. therefore, during infection antibacterial treatment may 
relieve bacterial imposed nutrient restriction resulting in secondary fungal infections.
Mucormycosis is a life threatening, disfiguring infection caused by ubiquitous environmental fungi belonging to 
the order Mucorales, with Rhizopus spp. accounting for approximately 70% of infections1,2. In healthy individuals, 
innate immune cells are capable of controlling spore germination, thus preventing infection3. However, patients 
with uncontrolled diabetes, cancer, neutropenia, burn/traumatic wounds, post-transplantation and those under-
going corticosteroid therapy or renal dialysis are prone to mucormycosis4,5. Mucorales are inherently resistant to 
antifungals, requiring surgical debridement of infected tissue followed by an aggressive antifungal regime. As a 
result, mucormycosis is associated with high mortality rates (up to 96% in disseminated infections), and signifi-
cant morbidity2.
Mucorales spores enter the body through inhalation or open wounds6. As a result mucormycosis is commonly 
associated with pulmonary, rhinocerebral, or cutaneous infections7. Germination is key to the pathogenesis of 
Mucorales, leading to tissue penetration, endothelial angioinvasion, and vessel thrombosis, ultimately result-
ing in debilitating necrosis4. Traumatic and burn wound infections, including military-associated blast wounds, 
are known predisposing conditions for mucormycosis in the immunocompetent2, with over 70% of these infec-
tions being polymicrobial in nature8,9. Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli are 
the most commonly co-isolated bacterial species from chronic wounds10,11, and are therefore likely to interact 
and compete with Mucorales spores. In addition, the emergence of mucormycosis has been associated with 
broad-spectrum antimicrobial treatment12–14, suggesting that the surrounding microbiome plays a role in con-
trolling fungal growth.
Here we show that P. aeruginosa inhibits the germination, and therefore virulence, of Rhizopus microsporus, a 
common cause of mucormycosis. This inhibition was mainly caused by bacterial secretion of iron-chelating mole-
cules, which sequester iron from the fungus. Considering the prevalence of opportunistic bacteria and Mucorales 
in traumatic wounds, antibacterial treatment may reduce the presence of nutrient-restricting molecules like bac-
terial secreted siderophores in the wound environment rendering the environment more permissive to fungal 
germination, although we acknowledge that other factors including the immune status of the host also play criti-
cal roles in controlling fungal infection.
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Results
Pseudomonas aeruginosa inhibits the germination of Rhizopus microsporus. Key to the pathogen-
esis of mucormycosis is the ability of spores to germinate and penetrate surrounding tissues4. To identify whether 
bacteria can influence fungal germination, R. microsporus spores were co-cultured with Pseudomonas aeruginosa, 
Burkholderia cenocepacia, Staphylococcus aureus, and Escherichia coli. Co-culture of R. microsporus with P. aerug-
inosa at multiplicities of infection (MOI) of 1:50 and 1:100 resulted in 56.8% (+/−8.269, p = 0.0023) and 92% 
(+/−2.784, p < 0.001) inhibition of fungal germination, respectively (Fig. 1A,B). Conversely, co-culturing R. 
microsporus spores with S. aureus, E. coli, and B. cenocepacia did not affect fungal growth at any of the MOIs tested 
(Fig. 1A). Taken together, the results obtained from live co-cultures between R. microsporus and P. aeruginosa 
indicate that these two microbes undergo a competitive relationship resulting in reduced fungal germination.
P. aeruginosa inhibits spore germination through secreted factors. Microbes are able to communi-
cate through the secretion of secondary metabolites, quorum sensing molecules, and metabolic by-products15–20. 
Therefore, to deduce whether the observed inhibition of R. microsporus germination was a result of direct cell-cell 
interactions or mediated through secreted products, R. microsporus spores were incubated in P. aeruginosa spent 
culture supernatants. Incubation of R. microsporus spores with 50% P. aeruginosa supernatant resulted in 94.4% 
(+/−0.01769, p = 0.0022) inhibition of fungal growth (Fig. 2A), confirming that the inhibitory molecule(s) are 
secreted by P. aeruginosa. Time-lapse microscopy confirmed that the presence of the supernatant resulted in a sig-
nificant reduction in spore germination (Fig. 2B,C, Videos 1 and 2), with only 6.7% (+/−3.8, p < 0.0001) of spores 
germinating after 18 h. However, the inhibition of germination did not affect spore swelling (Videos 1 and 2). 
To deduce whether P. aeruginosa supernatants are able to inhibit fungal growth after the initiation of germina-
tion, spores were pre-germinated, and then subsequently incubated with 50% supernatant. Fungal growth was 
significantly reduced (by 81.4% +/− 5.252, p = 0.0286) in the presence of the supernatant compared to the media 
Figure 1. Pseudomonas aeruginosa strongly inhibits the germination of Rhizopus microsporus. R. microsporus 
spores were incubated with live P. aeruginosa, B. cenocepacia, S. aureus, and E. coli at increasing multiplicities of 
infection (MOI) for 24 h (A) Representative images after 24 h exposure (37 °C, static). Scale bars depict 50 µm. 
(B) Per cent of spores germinated after 24 h exposure to P. aeruginosa. One-way ANOVA performed on arcsine 
transformed data (n = 6). ***p < 0.001. Error bars depict SEM.
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control (Fig. 2D). Therefore, P. aeruginosa supernatants are able to inhibit both germination and growth of R. 
microsporus.
To determine whether the inhibitory molecule(s) is produced by other P. aeruginosa strains, we tested the abil-
ity of supernatants from a series of P. aeruginosa isolates to inhibit spore germination. R. microsporus germination 
was inhibited in the presence of supernatants from all P. aeruginosa clinical isolates (Fig. 2E), suggesting that the 
production of this inhibitory molecule is a general trait of P. aeruginosa and is not limited to laboratory-evolved 
strains.
As fungal germination is dependent on environmental pH and nutrient availability21,22, we assessed whether 
the addition of the supernatant was inhibiting germination through modulation of these parameters. Addition 
of the bacterial supernatant to SAB broth resulted in mild alkalisation of the media (pH 7.33 vs. 6.45). However, 
adjusting the pH of the control media to pH 7.33, to mimic the conditions in media containing the P. aeruginosa 
supernatant, did not affect R. microsporus germination rates (Supplementary Fig. S1). To elucidate the role of 
Figure 2. P. aeruginosa inhibits spore germination through secreted factors. R. microsporus spores were 
exposed to 50% P. aeruginosa PAO1 supernatant for 24 h. (A) Fungal growth was measured through absorbance 
(OD600) and normalised to media control (n = 3). To determine the point of inhibition, spore germination was 
observed via live-cell imaging and (B) the per cent of spores germinated over time was quantified (n = 4, Two-
way ANOVA performed on arcsine transformed data). (C) Representative images of spores germinating over 
time were collected. Scale bar = 50 µm. (D) To determine whether the supernatant also inhibits the continuation 
of growth after germination is initiated, spores were incubated in SAB for 4–5 h until germlings emerged, and 
subsequently exposed to 50% PAO1 supernatant for 18 h (n = 4, Mann-Whitney U test). (E) To test whether this 
is a lab strain-specific phenomenon, R. microsporus spores were exposed to supernatants from P. aeruginosa 
clinical isolates for 24 h (n = 6). Fungal growth was determined through absorbance (OD600). All data was 
analysed by a Kruskal-Wallis test with Dunn’s multiple comparisons test unless indicated otherwise. *p < 0.05, 
**p < 0.01, ***p < 0.001. Error bars depict SEM.
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macronutrient restriction, SAB broth was diluted with 50% phosphate buffered solution (PBS) to mimic the 
nutrient limitation imposed by the addition of 50% supernatant. However, the spores were still able to germinate 
under these conditions (Supplementary Fig. S1). Therefore, P. aeruginosa secretes a molecule(s) that is able to 
inhibit R. microsporus germination independent of pH and macronutrient limitation.
Inhibition of R. microsporus germination is not mediated by quorum sensing molecules or pyocyanin. 
Bacteria secrete a diverse range of proteins and secondary metabolites to aid in host colonisation and inter-species 
competition. To determine whether the secreted factor responsible for inhibiting spore germination is protein-
aceous, P. aeruginosa supernatants were boiled or treated with Proteinase K to degrade any secreted proteins. 
Supernatants that were boiled or treated with Proteinase K inhibited R. microsporus growth (97.62%, +/−1.558, 
p = 0.0355 and 99.03%, +/−1.634, p = 0.0140, respectively) (Supplementary Fig. S2A), suggesting that a secreted, 
heat-stable molecule mediates the observed inhibition of R. microsporus germination.
P. aeruginosa secretes several heat-stable cell density-dependent signalling molecules into the envi-
ronment to regulate virulence by sensing population density and inducing the expression or inhibition of 
population-dependent mechanisms23. These quorum sensing molecules (QSMs) are well known to regulate intra- 
and inter-species interactions including inhibiting the morphological switch of Candida albicans24–27. Therefore, 
we tested the ability of the major P. aeruginosa QSMs to inhibit R. microsporus germination. Exposure of R. micro-
sporus spores to N-butanoyl-l-homoserine lactone (C4 HSL), N-hexanoyl-DL-homoserine lactone (C6 HSL), and 
N-octanoyl-L-homoserine lactone (C8 HSL), did not affect fungal growth (Supplementary Fig. S2B–D). At high 
concentrations (200 μM) N-(3-oxododecanoyl)-L-homoserine lactone (C12 HSL) resulted in 42.1% (+/−0.1518, 
p = 0.1331) reduction in fungal growth (Supplementary Fig. S2E). Therefore, secreted QSMs appear to not be the 
major regulators of R. microsporus growth.
Pyocyanin is a heat stable, secreted blue-pigmented toxin, which is known to increase the virulence of 
P. aeruginosa by depressing the host immune responses through induction of neutrophil apoptosis28,29. Pyocyanin 
also inhibits the growth and morphogenesis of C. albicans and Aspergillus fumigatus30. Therefore, we determined 
whether the presence of pyocyanin in the supernatant was inhibiting the germination of R. microsporus. Addition 
of purified pyocyanin resulted in 31.4% (+/−0.1434, p > 0.9999) inhibition of R. microsporus growth at con-
centrations above 100 μM (Supplementary Fig. S2F). To deduce whether these pyocyanin concentrations were 
physiologically relevant the concentration of pyocyanin in the P. aeruginosa supernatants was quantified through 
absorbance measurement (690 nm) and compared to a standard curve of pre-defined pyocyanin concentrations. 
Growth of P. aeruginosa in LB media at 200 rpm, 37 °C did not result in the secretion of detectable levels of pyo-
cyanin (not shown). Therefore, the inhibition of R. microsporus growth in the P. aeruginosa supernatant was not 
due to pyocyanin.
To determine whether the secreted factor is a lipophilic molecule, chloroform extractions were performed. 
The organic phase of the supernatant did not significantly inhibit spore germination (18% inhibition, +/−3.058, 
p = 0.0926), while the aqueous phase maintained its inhibitory action (95.1% inhibition, +/−0.9559, p = 0.0079, 
Supplementary Fig. S2G). Therefore, a secreted, heat-stable, water-soluble molecule(s) inhibits the growth of R. 
microsporus.
P. aeruginosa inhibits R. microsporus germination via iron sequestration. Research has estab-
lished the importance of metal micronutrients for microbial growth and pathogenicity, and the ability of host 
metal sequestering proteins to inhibit both fungal and bacterial growth through nutritional immunity31–33. Iron, 
zinc, copper, and manganese are considered the most important trace metals for the growth of fungi and the 
availability of iron is key to the pathogenesis of Mucorales34,35. Therefore, we investigated whether the super-
natants were imposing micronutrient restriction on R. microsporus. Supplementing the supernatants with iron 
was able to partially restore fungal growth, resulting in 46.2% R. microsporus growth at concentrations above 
200 µM (+/−6.660, Fig. 3A,C) and an insignificant difference as compared to the control (p > 0.9999). However, 
supplementation with zinc, copper or manganese did not rescue R. microsporus growth (Supplementary Fig. S3). 
Therefore, the majority of growth inhibition appears to result from the P. aeruginosa supernatants specifically 
sequestering iron from the environment. However, we acknowledge that other unidentified factors may play a role 
as supplementation with iron did not completely restore fungal growth. To confirm that the inhibition of spore 
germination observed in the co-cultures was also attributed to iron restriction, co-cultures of R. microsporus and 
P. aeruginosa were spiked with iron. Germination and therefore growth of R. microsporus in the co-culture was 
recovered at concentrations above 100 µM (41.9% +/− 12.46, p = 0.1540) to levels comparable to those observed 
for iron spiked supernatants (Fig. 3B), confirming that in both scenarios the major contributing factor, resulting 
in the inhibition of fungal growth, appears to be the sequestration of iron by P. aeruginosa.
Iron starvation has previously been shown to up-regulate the high affinity iron permease FTR1 in other 
Rhizopus species36. Therefore, to confirm that R. microsporus is undergoing iron starvation in the presence of P. 
aeruginosa supernatants, the expression levels of FTR1 were determined by qRT-PCR. FTR1 was highly upregu-
lated (10-fold increase, p = 0.0286) when exposed to 50% P. aeruginosa supernatant for 7 h, as compared to the 
control (Fig. 3D). This confirms that P. aeruginosa mediated iron restriction inhibits R. microsporus growth and 
germination.
Iron starvation has been shown to induce apoptosis in R. oryzae after prolonged starvation36. Therefore, if 
spores are undergoing iron starvation when exposed to P. aeruginosa supernatant, prolonged exposure should 
decrease survival. To isolate the effects of the supernatant, we used 100% P. aeruginosa supernatant to monitor 
spore survival over time. In this condition, the viability of spores was reduced by 82.40% (+/−13.44) after 24 h, 
and no viable spores were recovered after 120 h (p = 0.0490, Fig. 3E). This indicates that iron is essential for the 
survival and pathogenicity of R. microsporus.
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To delineate whether bacteria-associated iron restriction inhibits the growth of Mucorales in general, we 
tested the ability of P. aeruginosa supernatant to inhibit the growth of R. microsporus var. microsporus, R. micro-
sporus var. chinensis, R. delemar, and Mucor circinelloides. The growth of all isolates was significantly reduced 
in the presence of P. aeruginosa supernatant [83.85% (+/−15.23), 98.26% (+/−1.977), 99.01% (+/−0.8695), 
and 87.54% (+/−10.78), respectively], and was significantly rescued by the addition of 100 μM of iron [64.36% 
(+/−4.450), 41.30% (+/−10.48), 55.14% (+/−10.01), and 87.54% (+/−6.219), respectively]. This confirms that 
the bacteria-associated inhibition of growth is a general trait of Mucorales and highlights the potential differences 
between Mucorales strains in response to bacteria (Fig. 4).
Siderophore deficient P. aeruginosa strains lack the ability to suppress germination. Iron 
sequestering is mediated via iron binding proteins and molecules known as siderophores. Pyoverdine and pyoche-
lin are the two predominate siderophores produced by P. aeruginosa, with pyoverdine exhibiting the highest affin-
ity for iron37,38. To identify the role of these siderophores in this interaction, we quantified fungal growth in the 
presence of the supernatants from P. aeruginosa strains deficient in either siderophore alone, or in combination. 
Growth of R. microsporus was inhibited when incubated with culture supernatants from P. aeruginosa strains 
defective in pyochelin biosynthesis (∆pchEF), with growth being rescued by exogenous iron (Fig. 5A), suggest-
ing that this siderophore plays a minor role in sequestering iron in these experiments. However, R. microsporus 
Figure 3. P. aeruginosa inhibits R. microsporus germination via iron sequestration. R. microsporus spores were 
exposed to (A) 50% P. aeruginosa supernatant and spiked with increasing concentrations of iron chloride for 
24 h statically at 37 °C. Fungal growth was measured through absorbance (OD600) and normalised to media 
control (n = 3, Kruskal-Wallis test with Dunn’s multiple comparisons test). (B) This ability to rescue was 
confirmed in a live co-culture setting, where the addition of exogenous iron increased the per cent of spores 
germinated after 24 h in a dose-dependent manner (n = 8). As the addition of iron in 50% supernatant increased 
overall growth, (C) representative images were collected at 9 h to confirm ability to rescue germination. Scale 
bar depicts 50 µm. (D) Iron starvation of R. microsporus spores after 7 h exposure to P. aeruginosa supernatant 
was determined through strong upregulation of the high-affinity iron permease FTR1 (n = 4, Mann-Whitney 
U test). (E) As iron starvation is associated with Mucorales apoptosis, the viability of spores exposed to 100% P. 
aeruginosa supernatant over time was quantified by counting colony forming units (CFUs) every 24 h for 120 h 
(n = 3, Kruskal-Wallis test with Dunn’s multiple comparisons test). *p < 0.05, ***p < 0.001.
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germinated in the presence of bacterial supernatants from P. aeruginosa mutants defective in pyoverdine biosyn-
thesis (∆pvdD) or in pyoverdine and pyochelin biosynthesis (∆pchEF∆pvdD) (Fig. 5A), confirming that, under 
the tested conditions, P. aeruginosa imposed iron restriction is largely mediated by the secretion of pyoverdine.
To confirm that pyoverdine alone is sufficient to inhibit R. microsporus growth, spores were exposed to exog-
enous pyoverdine. P. aeruginosa supernatants contained 58.9 µg ml−1 (+/−1.194) siderophores, making the 
concentration of siderophores in our assay 29.45 µg ml−1. Therefore, R. microsporus spores were grown in the 
presence of 20 µg ml−1 purified pyoverdine to resemble siderophore concentrations similar to the culture super-
natants. Incubation of fungal spores with pyoverdine significantly reduced fungal growth (73.8%, +/−5.503, 
p = 0.0022, Fig. 5B). Therefore, pyoverdine alone is sufficient to inhibit R. microsporus growth and germination.
R. microsporus induces iron stress and promotes bacterial siderophore production. C. albicans 
can decrease P. aeruginosa siderophore production through suppression of the pyoverdine and pyochelin bio-
synthetic pathways19. To determine whether R. microsporus is also able to interfere with P. aeruginosa sidero-
phore production, the concentration of siderophores after 24 h mono- and co-culture was quantified (Fig. 5C). 
Surprisingly, the concentration of siderophores in mono-cultures in SAB/LB was lower than in LB (4.99 μg ml−1, 
+/−5.834, vs 58.9 µg ml−1 (+/−1.194)) suggesting that LB/SAB has a higher iron content, reducing siderophore 
production. However, in co-cultures, siderophore levels were increased to levels similar to the LB supernatant 
(53.25 μg ml−1, +/−0.4335 compared to 58.9 µg ml−1 (+/−1.194) indicative of imposed iron stress. This increase 
in siderophore concentration was not observed in co-cultures containing siderophore deficient P. aeruginosa 
(Fig. 5D), confirming that the increase in siderophore concentration is likely due to increased bacterial rather 
than fungal siderophore biosynthesis. In agreement with this, key genes involved in pyoverdine and pyochelin 
biosynthesis were upregulated during co-culture with R. microsporus. However, this regulation was lost in the 
presence of exogenous iron (Fig. 5E). These results confirm that during co-culture, the two organisms compete 
for iron, resulting in the upregulation of bacterial siderophore biosynthesis and P. aeruginosa outcompeting R. 
microsporus for iron and therefore growth.
the concentration of siderophores produced by bacteria correlates with inhibition of R. micro-
sporus growth. While live E. coli, B. cenocepacia, and S. aureus did not inhibit the growth of R. microspo-
rus, these bacteria all produce siderophores39–41. To determine the ability of secreted factors to inhibit growth, 
Figure 4. Iron-dependent inhibition of Mucorales by P. aeruginosa is not R. microsporus strain-specific. Most 
experiments in this study were performed using an R. microsporus clinical isolate. To ensure the inhibitory effect 
of P. aeruginosa is not limited to this isolate, R. microsporus var. microsporus, R. microsporus var. chinensis, R. 
delemar, and Mucor circinelloides were exposed to 50% P. aeruginosa supernatant with and without the addition 
of 100 µM FeCl3. Fungal growth was determined at 24 h by measuring absorbance (OD600) and normalising to 
control (n = 3). *p < 0.05. All data was analysed by a Kruskal-Wallis test with Dunn’s multiple comparisons test.
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R. microsporus spores were exposed to sterile supernatants from E. coli, B. cenocepacia and S. aureus to determine 
their ability to inhibit R. microsporus growth as compared to P. aeruginosa PAO1 and PA14. Consistent with the 
co-culture experiments, P. aeruginosa was the only supernatant able to significantly inhibit growth (Fig. 6A). We 
further investigated whether this lack of inhibition was associated with insufficient production of iron binding 
molecules by measuring the amount of siderophores produced after 24 h growth in LB. There was a negative 
correlation between fungal growth and siderophore production across different bacterial species (p = 0.0029, 
Fig. 6B), suggesting that siderophore mediated iron restriction may be a common mechanism of bacteria to 
compete with fungi. However, the presence of supernatants from E. coli had no effect on fungal growth. This 
was surprising, as E. coli produces enterobactin, a siderophore with a high affinity (1052 M) for iron42. In agree-
ment with this data, exogenous enterobactin did not inhibit R. microsporus growth (91%, +/−6.170, p = 0.936, 
Fig. 6C), suggesting that R. microsporus may utilise enterobactin as a xenosiderophore. Therefore, the addition of 
enterobactin in the presence of P. aeruginosa may provide an advantage to R. microsporus. To explore this possi-
bility, we added exogenous enterobactin to R. microsporus-P. aeruginosa co-cultures. However, the presence of the 
Figure 5. P. aeruginosa-imposed iron restriction is largely mediated via pyoverdine production. (A) R. microsporus 
was grown in bacterial supernatants from wild type P. aeruginosa, strains defective in siderophore biosynthesis, or 
standard LB mixed 25:75 with SAB, with and without iron. R. microsporus spores were exposed to these mixtures for 
24 h and fungal growth was determined via absorbance (OD600, n = 3). (B) R. microsporus spores were incubated in 
SAB with 20 μg ml−1 of exogenous pyoverdine at 37 °C for 24 h. Fungal growth was measured through absorbance 
(OD600) and normalised to media control (n = 6). (C) P. aeruginosa was exposed to R. microsporus at an MOI of 1:100 
(R. microsporus:P. aeruginosa) for 24 h (37 °C). Siderophore production was measured by using the Siderotec Assay 
(EmerginBio) (n = 3, Mann-Whitney U test). (D) P. aeruginosa strains defective in siderophore biosynthesis were 
exposed to R. microsporus at an MOI of 1:100 (R. microsporus:P. aeruginosa) for 24 h (37 °C). Siderophore production 
was measured by using the Siderotec Assay (EmerginBio) (n = 3, Mann-Whitney U test). (E) P. aeruginosa was 
exposed to R. microsporus at an MOI of 1:100 (R. microsporus:P. aeruginosa) for 7 h, snap frozen and total RNA 
extracted. The expression levels of PvdS and PchA were quantified by qRT-PCR relative to RpoD and normalised to 
PAO1 grown in isolation.
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enterobactin appeared to enhance the growth of the P. aeruginosa, presumably because P. aeruginosa can also uti-
lise enterobactin as a xenosiderophore. Therefore, instead we added enterobactin to sterile bacterial supernatants. 
R. microsporus displayed increased germination in P. aeruginosa supernatants supplemented with enterobactin, 
although fungal growth was not fully restored (Fig. 6D), presumably due to pyoverdine and pyochelin binding 
the majority of the free iron. Therefore, taken together this data indicates that R. microsporus can use enterobactin 
as a xenosiderophore.
the bacterial siderophore, pyoverdine, reduces the virulence of R. microspores. To determine 
whether the effects of the bacterial siderophores have a role in controlling fungal infection in the host, we utilised 
the zebrafish larval model (Fig. 7A). Co-injection of R. microsporus with pyoverdine (80 µg ml−1) resulted in a 
mild but significant increase in fish survival when compared to spores alone (Fig. 7B) with 89% (+/−6.377) of 
fish surviving across a 96-h time course. As a control to rule out any impact of the siderophore on innate immune 
cell function, fish were also infected with R. microsporus in the presence of enterobactin, which should induce 
iron restriction on the host, but not on the pathogen due to its ability to use enterobactin as a xenosiderophore. 
Unlike pyoverdine, the addition of enterobactin did not increase the survival of the larvae compared to larvae 
infected with R. microsporus alone (Fig. 7C). Together these data confirm that the presence of pyoverdine is suffi-
cient to reduce host damage caused by R. microsporus infection.
Figure 6. R. microsporus can utilise enterobactin as a xenosiderophore. (A) R. microsporus spores were 
exposed to 50% supernatants harvested from P. aeruginosa PAO1, P. aeruginosa PA14, B. cenocepacia, S. 
aureus, and E. coli for 24 h. Fungal growth was determined by absorbance (OD600) and normalised to control. 
(n = 6). (B) Concentration of siderophores produced by bacteria was determined by using the Siderotec 
Assay (EmerginBio). Correlation between total siderophore production and fungal growth was determined 
by performing a linear regression with Pearson correlation (n = 3). (C) R. microsporus spores were exposed 
to varying concentrations of purified enterobactin for 24 h at 37 °C (n = 3). Fungal growth was determined 
by absorbance (OD600) and normalised to control. (D) Enterobactin was added to PAO1 sterile supernatants 
diluted 50% with SAB to a final concentration of 50 μM and incubated at 37 °C for 24 h. Scale bar represents 
20 μm. All data was analysed by a Kruskal-Wallis test with Dunn’s multiple comparisons test unless indicated 
otherwise. *p < 0.05, **p < 0.01, ***p < 0.001.
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Discussion
Mucormycosis is a lethal infection with high mortality rates and lack of treatment options due to intrinsic anti-
fungal resistance43. Our current understanding of the pathogenesis is incomplete, especially when compared 
to other opportunistic fungal pathogens such as C. albicans and A. fumigatus. Because of this, it is important to 
understand the pressures Mucorales encounter within the human body. This not only includes pressures from 
the host, but also from the microbiota. Here we identify that P. aeruginosa is able to inhibit the germination of R. 
microsporus through the secretion of siderophores.
Pseudomonas species interact with and control the growth of a variety of fungal species including important 
plant and animal pathogens26,44,45. These interactions have been linked to a variety of contact dependent46 and 
bacterial secreted factors26,44,45. The most characterised secreted molecules known to affect fungal growth and 
morphology are the phenazines47,48 and the homoserine lactones26,44. For example, in C. albicans low levels of 
phenazines inhibit filamentation and biofilm formation, and are fungicidal at high concentrations49. Furthermore, 
the quorum sensing molecule, 3-oxo-C12-homoserine lactone (C12 HSL) induces apoptosis in C. albicans26 and 
A. fumigatus44. Despite this, these molecules had negligible impact on the growth of R. microsporus, confirming 
that other bacterial secreted factors control the growth of R. microsporus. However, high concentrations of C12 
HSL (200 µM) had a marginal effect on R. microsporus growth, indicating that intra-species QS may play a role in 
polymicrobial biofilms.
Instead we identified that this antagonistic relationship between P. aeruginosa and R. microsporus to be the 
result of competition for iron. Iron acquisition is key to Mucorales pathogenesis50. For example, medical condi-
tions (i.e. diabetic ketoacidosis) that result in increased serum levels of iron predispose individuals to mucor-
mycosis51, whereas iron chelation therapy, or reduction in fungal iron acquisition mechanisms reduce mortality 
in murine models of mucormycosis50,52. P. aeruginosa secretes several iron binding molecules, with pyoverdine 
being the major siderophore with a high affinity for iron. In agreement with this, we found that exogenous pyo-
verdine, at concentrations equal to those secreted by P. aeruginosa in our culture conditions, was sufficient to 
inhibit the growth of R. microsporus to levels comparable to the bacterial supernatant. In addition, deletion of key 
Figure 7. The bacterial siderophore, pyoverdine, reduces R. microsporus virulence in a zebrafish model of 
infection. To determine the impact of pyoverdine on fungal virulence within a host, zebrafish larvae were 
injected in the hindbrain with 50 spores +/−80 μg ml−1 pyoverdine. (A) Representative images of zebrafish 
larvae at 0 hpi. White arrows indicate R. microsporus spores (Calcofluor White stain, cyan pseudo-coloured) 
located within hindbrain compartment. Scale bars depict 100 μm. (B) Survival of larvae was quantified over 
time. Shown are data pooled from four separate experiments with a total of 87, 80, 80, and 81 fish for control, 
pyoverdine only, spores only, and spores + pyoverdine, respectively. Data analysed with Mantel-Cox log-rank 
test. (C) Survival of larvae was quantified over time. Data shown is pooled from two independent experiments 
with a total of 42, 44, 46, 43, and 50 fish for control, enterobactin only, spores only, and spores + enterobactin, 
respectively. Data analysed with Mantel-Cox log-rank test.
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enzymes in the biosynthesis pathways of the major P. aeruginosa siderophores was sufficient to reduce the effect 
of the bacterial supernatant, confirming a role for these siderophores in controlling fungal growth.
The presence of fungi has been shown to modulate the expression of siderophore biosynthetic genes in P. 
aeruginosa. For instance, C. albicans was described as down-regulating the production of pyoverdine and pyoche-
lin through secreted proteins19. Conversely, this study has found the production of pyoverdine to be increased in 
response to P. aeruginosa co-cultured with R. microsporus. This is clinically important, as pyoverdine production 
is directly linked to virulence of P. aeruginosa and is shown to modulate the production of other toxins53,54.
The addition of exogenous iron or the inhibition of bacterial siderophore production only resulted in the 
restoration of approximately 50% fungal growth compared to media only controls, suggesting that other factors 
also contribute to this inhibition. However, in Rhizopus oryzae, iron starvation induces apoptosis36, suggesting 
that spore viability may also be affected. In agreement with this, growth of R. microsporus in 100% P. aeruginosa 
supernatant decreased spore viability. As such, it is possible that reduced viability may account for the inability 
to completely rescue fungal growth. Interestingly though, exogenous iron was able to fully restore the growth of 
Mucor circinelloides, suggesting that M. circinelloides is less susceptible to apoptosis induced by iron starvation. 
Differences in the ability of iron to rescue growth between Mucorales strains also suggests the presence of other 
potential interactions beyond iron starvation.
R. microsporus can utilise some bacterial siderophores as sources of iron within the host, such as deferoxamine 
(a siderophore produced by some actinomycetes) to promote its growth and virulence55. However, unlike defer-
oxamine, and potentially enterobactin, R. microsporus cannot scavenge iron from pyoverdine, which suggests 
that molecules with similar structure may have the potential to be used to control mucormycosis. While utilising 
pyoverdine itself would be problematic due to its ability to enhance P. aeruginosa virulence54, this siderophore 
could provide a starting point for the development of novel iron chelators. Given that pyoverdine has also been 
shown to limit the growth of other invasive fungi, such as A. fumigatus18,56, molecules based on pyoverdine may 
have wide implications for the treatment of a range of invasive fungal diseases. This is further enforced by the fact 
that the presence of pyoverdine in our zebrafish larval model of infection was able to reduce mortality. Similar 
effects have also be observed in mouse models of infection where deferasirox protects against mycormycosis52. 
Therefore, iron chelation therapy could be an important preventative treatment for mucormycosis. However, it 
should be noted that iron is not only important for microbial growth, but also plays essential roles in immunity57. 
Consequently, iron chelation therapy may have unexpected effects on host immunity. For example, in C. elegans, 
pyoverdine has been shown to induce mitochondrial damage trigging autophagy and an altered host immune 
response58. Therefore, it is important to understand the consequences these iron scavenging molecules have on 
the host before such therapies are applied.
Taken together, our results agree with the current understanding of Mucorales pathogenesis where iron avail-
ability is considered essential for pathogenesis. However, here we present this in a different scenario where iron 
availability is controlled by surrounding bacteria. Given that a high percentage of invasive mucormycosis results 
from burn and blast wound infections, where iron availability will be high due to tissue damage, we propose that 
opportunistic bacteria like P. aeruginosa will sequester iron away from the fungus restricting fungal growth. In 
agreement with this, burn wound exudate enhances P. aeruginosa siderophore production59 resulting in high con-
centrations of pyoverdine in the wound. However, antibiotic treatment would reduce this competition for iron, 
and promote fungal germination. This, coupled with natural immunosuppression following trauma could lead to 
aggressive secondary mucormycosis60. Therefore, patients that have potentially been exposed to fungal spores (i.e. 
soldiers with blast wounds where significant environmental contamination of the wound has occurred) should be 
closely monitored for secondary fungal infections. The discovery of suitable iron chelators that do not promote 
bacterial virulence would be advantageous in this setting to help prevent fungal infection.
Methods
ethics. Zebrafish care and experiments were performed under Home Office project license P51AB7F76 and 
personal license I5B923969 in accordance with the Animal Scientific Procedures Act 1986.
strains and culture conditions. All media and chemicals were purchased from Sigma-Aldrich unless 
stated otherwise. For details of fungal and bacterial strains used, please see (Table 1). R. microsporus was routinely 
sub-cultured and maintained on Sabouraud 4% dextrose agar (SAB, Merck Millipore, Germany) and incubated 
for 10–14 days before use (25 °C). Bacteria were maintained on Lysogeny broth (LB) with 2% agar.
Live co-cultures. LB broth was inoculated with P. aeruginosa, B. cenocepecia, E. coli, or S. aureus and 
incubated for 24 h (37 °C, 200 rpm). Bacteria were washed three times with phosphate buffered solution (PBS). 
R. microsporus sporangiospores were harvested through flooding with PBS, washed once, and counted via haemo-
cytometer. Spores (1 × 104 spores/ml) were added to 50% SAB, 50% LB in a 96-well plate. Bacteria were added 
to each well at a multiplicity of infection (MOI) ratio of 1:1, 1:10, 1:50, and 1:100 and incubated for 24 h (static, 
37 °C). Wells were imaged using an inverted Zeiss AxioObserver microscope (20x magnification) and the number 
of germinated spores per field of view quantified. Germination was defined as the point in which the germ tube 
reached the same size as the spore diameter.
spore germination when exposed to bacterial supernatants. Bacterial cultures were prepared as 
previously detailed and grown to at least stationary phase (OD600 > 3.0). Cultures were centrifuged (3220 × g, 
10 min) and the resulting supernatant filter sterilised. Sterile supernatants were stored at −80 °C until required. 
Spores (1 × 104/ml) were added to a 96-well plate containing either 50% SAB and 50% LB broth, or 50% SAB 
and 50% supernatant. Fungal growth was determined by endpoint analysis using OD600 as a quantifier of growth 
(FLUOstar Omega plate reader).
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To investigate the role of iron restriction, ferric chloride (100 mM) was diluted to 1, 10, 50, 100, 200, and 
500 µM in supernatants. The iron was allowed to associate with any chelating molecules for 15 min before the 
addition of an equal volume of SAB. Wells containing the SAB/supernatant mixture without iron were included 
as controls.
Live cell imaging. Live-cell imaging was performed for 12–18 h at 37 °C with humidity using a Zeiss 
AxioObserver microscope (20x magnification). Images were taken every 10 min to create a time-lapse movie, 
and the percentage of germinated spores in each field of view was determined.
exposure of pre-germinated spores to P. aeruginosa supernatant. Spores were harvested and 
added to 500 µl of SAB broth at a concentration of 1 × 106 spores/ml in triplicate in a 24 well plate. Spores were 
incubated statically for 4–5 h at 37 °C until germlings emerged and then either 500 µl of P. aeruginosa supernatant 
or 500 µl LB was added. The plate was incubated for 18 h at 37 °C, and the endpoint absorbance (OD600) of each 
well measured.
Viability of spores exposed to P. aeruginosa supernatant. R. microsporus spores (1 × 106 spores/ml) 
were exposed to 100% P. aeruginosa supernatant for 96 h (statically, 37 °C). Every 24 h, 100 spores were plated on 
SAB agar and incubated at 25 °C for 24 h. Following incubation, the number of viable spores were counted and 
compared to 0 h control plates.
pyocyanin secretion. P. aeruginosa supernatants were prepared as described previously. Absorbance 
(690 nm) was measured using a FLUOstar Omega plate reader and compared to a pyocyanin standard curve.
RNA extraction of fungi. R. microsporus spores (2.5 × 106 spores/ml) were exposed to SAB/LB (50:50) 
(media only control) or 50% PAO1 supernatant. Flasks were incubated statically at 37 °C for 7 h. Spores were 
centrifuged (1,811 × g, 3 min), snap frozen in liquid nitrogen, and stored at −80 °C. When ready to extract RNA, 
1 ml of TRIzol (Invitrogen) was added to each sample and thawed on ice. These samples were homogenised as 
before. Chloroform (200 µl) was added to each sample, vortexed thoroughly, and centrifuged at 4 °C, 9,400 × g for 
15 min. The aqueous layer was collected, and an equal volume of 100% ethanol was added. 700 µl of this was trans-
ferred to RNeasy columns, and the RNeasy Mini Plus Kit (Qiagen) protocol followed according to manufacturer 
guidelines. The RNA concentration and quality were measured using a spectrophotometer.
RNA extraction of bacteria. P. aeruginosa (1 × 108 CFUs/ml) were exposed to 50:50 SAB/LB (+/−100 μM 
FeCl3) or R. microsporus spores (1 × 106 spores/ml, +/−100 μM FeCl3). Flasks were incubated at 37 °C and 50 rpm 
for 7 h. Cultures were centrifuged (6,000 × g for 3 min), snap frozen in liquid nitrogen, and stored at −80 °C. The 
RNeasy Mini Plus Kit (Qiagen) protocol for purification of total RNA from bacteria was followed according to 
manufacturer guidelines. The RNA concentration and quality were measured using a spectrophotometer.
Quantitative Reverse transcriptase pCR. qRT-PCR was performed using an iTaq Universal SYBR Green 
One-Step Kit (Bio Rad) using 50 ng RNA with a total reaction volume of 20 μl. Protocol was followed according 
to manufacturer’s recommendations. FTR1 was amplified using the forward primer (5′-GTGGTGTCTCCTTGG 
GTGTT-3′) and reverse primer (5′-CCACCACGGTAGATGAGGA-3′). This was normalised to 18 s rRNA using 
the forward primer (5′-GGCGACGGTCCACTCGATTT-3′) and reverse primer (5′-TCACTACCTCCCCGT 
GTCGG-3′).
PvdS was amplified using the forward primer (5′-ACCGTACGATCCTGGTGAAG-3′) and reverse primer (5′- 
TGAACGACGAAGTGATCTGC-3′). PchA was amplified using the forward primer (5′- CTGCCTGTACTGG 
GAACAGC-3′) and reverse primer (5′-GCAGAGCAATTGCCAGTTTT-3′). These were normalised to rpoD 
using the forward primer (5′-GGGCGAAGAAGGAAATGGTC-3′) and the reverse primer (5′-CAGGTGGCGTA 
GGTGGAGAA-3′).
Strain Characteristics Source
Rhizopus microsporus 12.6652333 Clinical isolate Queen Elizabeth Hospital Birmingham
R. microsporus var. microsporus CBS 699.68 Clinical isolate Westerdijk Fungal Biodiversity Institute
R. microsporus var. chinensis CBS 631.82 Clinical isolate Westerdijk Fungal Biodiversity Institute
R. delemar RA 99–880 Clinical isolate Fungal Genetics Stock Centre
Mucor circinelloides NRRL3631 Clinical isolate ARS Culture Collection (NRRL)
Burkholderia cenocepecia K56–2 Clinical isolate from cystic fibrosis Amy Dumigan, Queen’s University Belfast
Staphylococcus aureus MRSA Wild type Anne-Marie Krachler, University of Texas
Escherichia coli MG1655 Wild type Anne-Marie Krachler, University of Texas
Pseudomonas aeruginosa PAO1 ATCC15692 Wild type ATCC
P. aeruginosa PAO1 Wild type 62,63
P. aeruginosa ΔpchEF PAO1, deleted pyochelin 63
P. aeruginosa ΔpvdD PAO1, deleted pyoverdine 63
P. aeruginosa ΔpchEFΔpvdD PAO1, deleted pyochelin and pyoverdine 63
Table 1. Strains used in this study.
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Quantification of overall siderophore production. Siderophore concentrations in bacterial super-
natants were quantified by using the SideroTec Assay Kit (Emergen Bio) according to the manufacturer 
recommendations.
Zebrafish infections. Adult wild type (AB) Danio rerio zebrafish were maintained at the University of 
Birmingham Aquatic Facility in recirculating tanks with 14 h light/10 h dark cycles at 28 °C. Adult zebrafish nat-
urally spawned overnight in groups of 11 fish (six female, five males). Embryos were transferred to E3 medium 
(5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4, pH 7) with 0.3 µg ml−1 methylene blue and 0.003% 
1-phenyl-2-thiourea (PTU) for the first 24 hours post fertilisation (hpf) and maintained at 32 °C.
Hindbrain injections were performed as previously described61. Sample sizes were calculated via power anal-
ysis using an alpha value of 0.05, power of 80%, mean effect size of 4.2%, and standard deviation of 8%, based 
on preliminary data and standards accepted by the zebrafish infection community. At 24 hpf larvae were man-
ually dechorionated and anaesthetised (160 µg ml−1 Ethyl 3-aminobenzoate methanesulfonate salt [Tricaine]). 
R. microsporus spores were suspended in either polyvinylpyrrolidone (PVP, 10% in PBS + 0.05% phenol red), 
PVP + 80 µg ml−1 pyoverdine, dimethyl sulfoxide (DMSO, solvent for enterobactin) or 33.5 μg ml−1 enterobactin 
at a concentration of 5 × 106 spores/ml. Suspended spores (2 nl) were injected into the hindbrain via the otic ves-
icle to achieve a dose of 50 spores/larva. Control larvae were injected with either PVP only or PVP + 80 µg ml−1 
pyoverdine. Any fish that did not survive the injection process were removed. Survival was recorded every 24 h 
until larvae were sacrificed at 5 dpf (96 hours post infection) through 10x overdose of Tricaine. For the pyoverdine 
experiment, data were pooled from four separate experiments with a total of 87, 80, 80, and 81 fish for control, 
pyoverdine only, spores only, and spores + pyoverdine, respectively. For the enterobactin experiment, data were 
pooled from two separate experiments with a total of 42, 44, 46, 43, and 50 fish for control, DMSO, enterobactin 
only, spores only, and spores + enterobactin, respectively.
statistical analysis. Each experiment was performed with at least two technical and two biological repli-
cates. Microsoft Excel 2016 and GraphPad Prism 6 were used to record and analyse data. Statistical tests used are 
indicated in figure legends. All analysis was performed on non-normalised raw data or arcsine transformed data 
where appropriate. A p-value of p < 0.05 was considered to indicate statistical significance. Statistical significance 
is indicated by *p < 0.05, **p < 0.01, and ***p < 0.001.
Data Availability
The datasets generated during this study are available from the corresponding author upon reasonable request.
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